These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

163 related items for PubMed ID: 3667382

  • 1. A microdosimetric model of astatine-211 labeled antibodies for radioimmunotherapy.
    Humm JL.
    Int J Radiat Oncol Biol Phys; 1987 Nov; 13(11):1767-73. PubMed ID: 3667382
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Vascular-targeted radioimmunotherapy with the alpha-particle emitter 211At.
    Kennel SJ, Mirzadeh S, Eckelman WC, Waldmann TA, Garmestani K, Yordanov AT, Stabin MG, Brechbiel MW.
    Radiat Res; 2002 Jun; 157(6):633-41. PubMed ID: 12005541
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Applications of 211At and 223Ra in targeted alpha-particle radiotherapy.
    Vaidyanathan G, Zalutsky MR.
    Curr Radiopharm; 2011 Oct; 4(4):283-94. PubMed ID: 22202151
    [Abstract] [Full Text] [Related]

  • 7. Targeted therapy using alpha emitters.
    Vaidyanathan G, Zalutsky MR.
    Phys Med Biol; 1996 Oct; 41(10):1915-31. PubMed ID: 8912371
    [Abstract] [Full Text] [Related]

  • 8. Radioimmunotherapy of nude mice with intraperitoneally growing ovarian cancer xenograft utilizing 211At-labelled monoclonal antibody MOv18.
    Andersson H, Lindegren S, Back T, Jacobsson L, Leser G, Horvath G.
    Anticancer Res; 2000 Oct; 20(1A):459-62. PubMed ID: 10769696
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Comparative tissue distribution in mice of the alpha-emitter 211At and 131I as labels of a monoclonal antibody and F(ab')2 fragment.
    Garg PK, Harrison CL, Zalutsky MR.
    Cancer Res; 1990 Jun 15; 50(12):3514-20. PubMed ID: 2340501
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Inactivation of human osteosarcoma cells in vitro by 211At-TP-3 monoclonal antibody: comparison with astatine-211-labeled bovine serum albumin, free astatine-211 and external-beam X rays.
    Larsen RH, Bruland OS, Hoff P, Alstad J, Lindmo T, Rofstad EK.
    Radiat Res; 1994 Aug 15; 139(2):178-84. PubMed ID: 8052693
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. 211At radioimmunotherapy of subcutaneous human ovarian cancer xenografts: evaluation of relative biologic effectiveness of an alpha-emitter in vivo.
    Bäck T, Andersson H, Divgi CR, Hultborn R, Jensen H, Lindegren S, Palm S, Jacobsson L.
    J Nucl Med; 2005 Dec 15; 46(12):2061-7. PubMed ID: 16330571
    [Abstract] [Full Text] [Related]

  • 19. Therapeutic efficacy of the alpha-emitter 211At bound on microspheres compared with 90Y and 32P colloids in a murine intraperitoneal tumor model.
    Vergote I, Larsen RH, de Vos L, Nesland JM, Bruland O, Bjørgum J, Alstad J, Tropé C, Nustad K.
    Gynecol Oncol; 1992 Dec 15; 47(3):366-72. PubMed ID: 1473751
    [Abstract] [Full Text] [Related]

  • 20. Therapeutic efficacy of astatine-211-labeled trastuzumab on radioresistant SKOV-3 tumors in nude mice.
    Palm S, Bäck T, Claesson I, Danielsson A, Elgqvist J, Frost S, Hultborn R, Jensen H, Lindegren S, Jacobsson L.
    Int J Radiat Oncol Biol Phys; 2007 Oct 01; 69(2):572-9. PubMed ID: 17869670
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.